Omega Healthcare (OHI) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.19
- EPS estimate
- $0.51
- EPS surprise
- +133.98%
- Revenue surprise
- −1.59%
- Revenue
- $262.7M
- Revenue estimate
- $267.0M
- Reported
- Jul 29, 2026
Omega Healthcare reported Q2 2026 results on July 29, 2026. Earnings per share were $1.19, far above the $0.51 estimate, a 133.98% beat. Revenue was $262.7 million, slightly below the $267.0 million consensus. Compared with Q2 2025, EPS more than doubled from $0.46 and revenue rose about 11% from $235.6 million.
The Q2 2026 figure is unusually high for this record. In the other 19 quarters shown, EPS ranged from $0.14 to $0.79. Results have swung widely against estimates, with 10 beats and 10 misses over 20 quarters. Annual EPS was $1.79 in 2022, fell to $0.99 in 2023, then rose to $1.55 in 2024 and $1.93 in 2025. Quarterly revenue rose year over year in each of the last eight quarters, reaching a high of $266.9 million in Q1 2026. The first half of 2026 adds up to $1.66 per share, already close to the 2025 total.
Omega Healthcare reported Q3 between October 30 and November 4 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether EPS stays near the Q2 level or returns to the range of earlier quarters.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | $0.51 | $1.19 | +133.98% | $262.7M | SEC |
| Q1 2026 | Apr 28, 2026 | $0.48 | $0.47 | −3.01% | $266.9M | SEC |
| Q4 2025 | Feb 4, 2026 | $0.50 | $0.55 | +11.07% | $261.4M | SEC |
| Q3 2025 | Oct 30, 2025 | $0.46 | $0.59 | +27.73% | $260.7M | SEC |
| Q2 2025 | Jul 31, 2025 | $0.43 | $0.46 | +7.45% | $235.6M | SEC |
| Q1 2025 | May 1, 2025 | $0.45 | $0.33 | −25.88% | $228.4M | SEC |
| Q4 2024 | Feb 5, 2025 | $0.43 | $0.41 | −5.09% | $230.8M | SEC |
| Q3 2024 | Oct 30, 2024 | $0.39 | $0.42 | +9.01% | $227.8M | SEC |
| Q2 2024 | Aug 1, 2024 | $0.36 | $0.45 | +26.65% | $210.4M | SEC |
| Q1 2024 | May 2, 2024 | $0.32 | $0.27 | −15.33% | $203.2M | SEC |
| Q4 2023 | Feb 7, 2024 | $0.35 | $0.22 | −37.05% | $204.0M | SEC |
| Q3 2023 | Nov 2, 2023 | $0.33 | $0.37 | +11.14% | $205.9M | SEC |
| Q2 2023 | Aug 2, 2023 | $0.31 | $0.25 | −18.91% | $215.0M | SEC |
| Q1 2023 | May 2, 2023 | $0.28 | $0.15 | −46.81% | $185.1M | SEC |
| Q4 2022 | Feb 2, 2023 | $0.55 | $0.19 | −65.58% | $110.1M | SEC |
| Q3 2022 | Nov 2, 2022 | $0.39 | $0.43 | +10.26% | $203.2M | SEC |
| Q2 2022 | Aug 1, 2022 | $0.38 | $0.38 | −1.12% | $207.5M | SEC |
| Q1 2022 | May 2, 2022 | $0.33 | $0.79 | +139.39% | $213.3M | SEC |
| Q4 2021 | Feb 2, 2022 | $0.47 | $0.14 | −70.00% | $214.3M | SEC |
| Q3 2021 | Nov 4, 2021 | $0.43 | $0.58 | +34.88% | $243.6M | SEC |
Quarterly revenue
Frequently asked questions
When did Omega Healthcare (OHI) last report earnings?
Omega Healthcare last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did OHI beat earnings estimates?
Yes. Omega Healthcare reported EPS of $1.19 for Q2 2026 against a $0.51 estimate — a 133.98% beat.
How much revenue did OHI report last quarter?
Omega Healthcare reported $262.7M in revenue for Q2 2026, against a consensus estimate of $267.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.